deus medical semaglutide Flex-Dose 2 mL Injectable 2.5 mg/mL prime body semaglutide Semaglutide for

The medication creates favourable conditions for lifestyle changes but cannot overcome poor dietary choices or sedentary behaviour

Semaglutide and tirzepatide are FDA-approved with extensive clinical trial data showing average 15-20% body weight loss, improvements in cardiovascular health markers, reduction in obesity-related disease risk, and excellent safety profile with proper medical supervision

Indulekha K, Anjana RM, Surendar J, Mohan V

Ding Y, Floren M, Tan W (2017) High-throughput screening of vascular endothelium-destructive or protective microenvironments: cooperative actions of extracellular matrix composition, stiffness, and structure

Better Body Composition: This combo helps you lose fat while maintaining or even gaining lean mass, ideal for sustainable weight loss

This isn't the first time that the agency has targeted telehealth companies and compounding pharmacies for marketing the popular weight-loss drugs without authorization